pharma · T2DM (Type 2 Diabetes Mellitus) · Type 2 Diabetes Mellitus · ORMP
Oramed Pharmaceuticals
ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 20 Mamilla Avenue, 3rd Floor, Jerusalem, 9414904, IL
- Founded
- 2006
- Employees
- 16
- Programs
- 14
- Drugs
- 8
- Patents
- 10
Oramed Pharmaceuticals projects
4 ClinicalTrials.gov programs sponsored by Oramed Pharmaceuticals.
Oramed Pharmaceuticals has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ORMD-0801
ORAMED PHARMACEUTICALS INC.
Diabetes Mellitus, Type 2
2 trials -
ORMD-0801
ORAMED PHARMACEUTICALS INC.
T2DM (Type 2 Diabetes Mellitus)
1 trial -
ORMD-0801 (qd)
ORAMED PHARMACEUTICALS INC.
Type 2 Diabetes Mellitus
2 trials -
ORMD-0801 8 mg
ORAMED PHARMACEUTICALS INC.
Type 2 Diabetes Mellitus
1 trial
Frequently asked questions
How many clinical projects does Oramed Pharmaceuticals have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.